The Centers for Medicare & Medicaid Innovation Center is working with drug makers like Eli Lilly and Novo Nordisk to make GLP-1 medications more affordable for state Medicaid programs and beneficiaries alike
240 Chronic circadian rhythm disruption has been linked to increased risks of neurologic, psychiatric, cardiovascular, metabolic, digestive, and infectious diseases, as well as some cancers and mortality
These medications, originally developed to treat diabetes and support weight management, have been linked to severe gastrointestinal injuries, stomach paralysis, vision loss, and other serious health complications
Mukai, T., Kishi, T., Matsuda, Y., & Iwata, N
One group was given 1000 mg of GliSODin once daily for two weeks prior to the test, while the placebo group received 1000 mg of wheat gliadin alone